Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Memantine enters phase I for AIDS-related dementia, painful peripheral neuropathies

Aug. 30, 1996

Synapton phase III trials concluded

Aug. 30, 1996

Prednisone suppresses acute phase in AD patients

Aug. 30, 1996

Botulinum toxin effective in treating writer's cramp

Aug. 30, 1996

Botulinum toxin effective in reducing upper limb spasticity

Aug. 30, 1996

Roche files for approval of Tasmar

Aug. 30, 1996

Tegretol-XR launched in U.S.

Aug. 30, 1996

CGP-25454 tested in healthy volunteers

Aug. 30, 1996

Correlation established between serum PLA2 activity and schizophrenia symptoms

Aug. 30, 1996

Potential antipsychotic described by Parke-Davis

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 26, 2025
Lost in trans-lation? Trump’s mouse charge doesn’t click
BioWorld
U.S. President Donald Trump touched off a not-uncommon flurry of puzzlement and outrage when, during his speech to Congress on March 4, he referred to an example...
Gene therapy efforts active, despite low Bluebird, 2seventy bids
BioWorld
Bristol Myers Squibb Co.’s decision this week to snag Bluebird Bio Inc. spinout 2seventy Bio Inc. for $102 million net – just weeks after investors bid $30...
CMV history cited in DMD liver death on Sarepta’s Elevidys
BioWorld
Wall Street was weighing the gravity of the death from acute liver failure of a patient who was treated for Duchenne muscular dystrophy (DMD) with Sarepta...